Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) Other Current Liabilities: ¥4.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603207 Shanghai Xiao Fang Pharmaceutical Co Ltd SHSE:603207
41 GF Score
Price ¥23.09
! 3 Warning Signs
View Full Analysis

What is Shanghai Xiao Fang Pharmaceutical Co Other Current Liabilities?

Shanghai Xiao Fang Pharmaceutical Co SHSE:603207 -0.69% 41 Other Current Liabilities is ¥4.9 Mil as of Jun. 2026. GuruFocus rates SHSE:603207 with a GF Score™ of 41/100. The stock has 3 warning signs investors should review.

Shanghai Xiao Fang Pharmaceutical Co's other current liabilities for the quarter that ended in Jun. 2026 was ¥4.9 Mil.

Shanghai Xiao Fang Pharmaceutical Co's quarterly other current liabilities increased from Dec. 2025 (¥11.0 Mil) to Mar. 2026 (¥11.0 Mil) but then declined from Mar. 2026 (¥11.0 Mil) to Jun. 2026 (¥4.9 Mil).

Shanghai Xiao Fang Pharmaceutical Co's annual other current liabilities increased from Dec. 2023 (¥2.4 Mil) to Dec. 2024 (¥3.8 Mil) and increased from Dec. 2024 (¥3.8 Mil) to Dec. 2025 (¥11.0 Mil).

Shanghai Xiao Fang Pharmaceutical Co Other Current Liabilities Related Terms

Shanghai Xiao Fang Pharmaceutical Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Shanghai Xiao Fang Pharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Xiao Fang Pharmaceutical Co Other Current Liabilities Chart

Shanghai Xiao Fang Pharmaceutical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 14.20 2.97 2.41 3.82 10.97

Shanghai Xiao Fang Pharmaceutical Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.87 2.83 10.97 11.02 4.92
SHSE:603207
41GF Score
Shanghai Xiao Fang Pharmaceutical Co Ltd SHSE:603207
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Xiao Fang Pharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ¥4.9 Mil mean?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a Other Current Liabilities of ¥4.9 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shanghai Xiao Fang Pharmaceutical Co.
Is Shanghai Xiao Fang Pharmaceutical Co's Other Current Liabilities too high?
Shanghai Xiao Fang Pharmaceutical Co's current Other Current Liabilities is ¥4.9 Mil. Overall, Shanghai Xiao Fang Pharmaceutical Co has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xiao Fang Pharmaceutical Co's Other Current Liabilities compare to ZTS?
Shanghai Xiao Fang Pharmaceutical Co's Other Current Liabilities of ¥4.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Shanghai Xiao Fang Pharmaceutical Co. Shanghai Xiao Fang Pharmaceutical Co's current Other Current Liabilities is ¥4.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xiao Fang Pharmaceutical Co stock overvalued right now?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a current Other Current Liabilities of ¥4.9 Mil. The current Other Current Liabilities is ¥4.9 Mil. Shanghai Xiao Fang Pharmaceutical Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207), the current Other Current Liabilities is ¥4.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Xiao Fang Pharmaceutical Co Business Description

Address No. 777, Hongzhu Road, Fengxian District, Shanghai, CHN, 201411
Shanghai Xiao Fang Pharmaceutical Co Ltd is engaged in Research and development, production and sales of topical medicines.
41GF Score

Get the complete analysis for SHSE:603207

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.09
Price